Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
52,953 Cancer
clinical trials

Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
945
mi
from
Helena, MT
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
959
mi
from
Henderson, NV
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
3718
mi
from
Honolulu, HI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
572
mi
from
Houston, TX
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1152
mi
from
Jacksonville, NC
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
194
mi
from
Kansas City, MO
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
214
mi
from
Kearney, NE
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
749
mi
from
Kettering, OH
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
783
mi
from
Lansing, MI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
960
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
970
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
970
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
968
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
219
mi
from
Lawton, OK
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1229
mi
from
Lewes, DE
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
220
mi
from
Lincoln, NE
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
789
mi
from
Logan, UT
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
401
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1169
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
656
mi
from
Louisville, KY
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
433
mi
from
Loveland, CO
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
394
mi
from
Marshalltown, IA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1285
mi
from
Marysville, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
797
mi
from
Maumee, OH
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
600
mi
from
Maywood, IL
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
478
mi
from
Memphis, TN
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
841
mi
from
Mount Vernon, OH
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1058
mi
from
Nampa, ID
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
697
mi
from
New Orleans, LA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
694
mi
from
New Orleans, LA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1288
mi
from
New York, NY
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
843
mi
from
Newark, OH
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
34
mi
from
Newton, KS
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1348
mi
from
North Haven, CT
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1330
mi
from
Oakland, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1327
mi
from
Oakland, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
731
mi
from
Ooltewah, TN
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1154
mi
from
Orange, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
253
mi
from
Papillion, NE
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1162
mi
from
Pasadena, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
479
mi
from
Pekin, IL
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
485
mi
from
Peoria, IL
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
524
mi
from
Peru, IL
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
969
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
971
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
975
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1388
mi
from
Portland, OR
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
51
mi
from
Pratt, KS
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
371
mi
from
Pueblo, CO
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1398
mi
from
Puyallup, WA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
768
mi
from
Reed City, MI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1188
mi
from
Reno, NV
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1190
mi
from
Reno, NV
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1130
mi
from
Riverside, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1271
mi
from
Roseville, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1283
mi
from
Sacramento, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
671
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
214
mi
from
Saint Joseph, MO
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
76
mi
from
Salina, KS
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1136
mi
from
San Diego, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1327
mi
from
San Leandro, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1188
mi
from
Sandpoint, ID
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1350
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
995
mi
from
Seneca, PA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
753
mi
from
Sidney, OH
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
903
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1194
mi
from
Spokane Valley, WA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
252
mi
from
Springfield, MO
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
406
mi
from
Sunset Hills, MO
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1408
mi
from
Tacoma, WA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1408
mi
from
Tacoma, WA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
413
mi
from
Thornton, CO
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
793
mi
from
Traverse City, MI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
984
mi
from
Uniontown, PA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1327
mi
from
Vallejo, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1385
mi
from
Vancouver, WA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1231
mi
from
Vineland, NJ
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1127
mi
from
Washington DC,
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
374
mi
from
Washington, MO
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
652
mi
from
Weston, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Neoadjuvant Nivolumab With and Without Urelumab in Patients With Cisplatin-Ineligible Muscle-Invasive Urothelial Carcinoma of the Bladder
Status: Enrolling, Phase II
Updated: 12/31/1969
1286
mi
from
New York, NY
Click here to add this to my saved trials
Brain Cancer Clinical Trial
Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas
Status: Enrolling
Updated: 12/31/1969
1289
mi
from
New York, NY
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer
Status: Enrolling, Phase I, II
Updated: 12/1/2016
1068
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Hepatocellular Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)
Status: Enrolling, Phase II
Updated: 12/31/1969
1383
mi
from
Portland, OR
Click here to add this to my saved trials
Hepatocellular Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)
Status: Enrolling, Phase II
Updated: 12/31/1969
1112
mi
from
Fairfax, VA
Click here to add this to my saved trials
Hepatocellular Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)
Status: Enrolling, Phase II
Updated: 12/31/1969
1286
mi
from
New York, NY
Click here to add this to my saved trials
Hepatocellular Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)
Status: Enrolling, Phase II
Updated: 12/31/1969
1378
mi
from
Vancouver, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
1295
mi
from
Bronx, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
610
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
1052
mi
from
Durham, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
618
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
262
mi
from
Omaha, NE
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 4/23/2018
607
mi
from
Munster, IN
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 4/23/2018
835
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1181
mi
from
Norfolk, VA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
787
mi
from
Pensacola, FL
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1204
mi
from
Wilmington, DE
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1145
mi
from
Baltimore, MD
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1575
mi
from
Bangor, ME
Click here to add this to my saved trials